Semaglutide is designed for ongoing weekly use
Managing side effects through dose titration Most gastrointestinal side effects are dose-dependent and transient
Against Phentermine/Topiramate, Semaglutide showed significant associations with reduced dry eye disease (HR 0.26, 95% CI: 0.130.50, p = 2 10 5 ) and visual disturbances (HR 0.61, 95% CI: 0.380.97, p = 0.037)
The clinical trial numbers The STEP trial program the most comprehensive clinical evidence for semaglutide's weight loss effects enrolled thousands of patients across multiple countries over 68 weeks
Read Also The applications could bring more affordable versions of one of the worlds most sought-after medicines into one of Africas largest and most developed healthcare markets, putting further pressure on Novo Nordisk and its US rival, Eli Lilly
This guarantees adherence to stringent quality standards and regulatory guidelines